Raymed Labs Ltd — Results, 22-05-2025: Result

Cresanto Global Limited has announced a board meeting approving the financial results for the quarter and half-year. The company reported total income of ₹51.73 lakh for the year, primarily from other income, with no revenue from operations. Expenses increased to ₹70.64 lakh, driven by employee benefits and other expenses, resulting in a loss before tax of ₹18.05 lakh compared to a loss of ₹10.16 lakh in the previous year. Statutory auditors issued an unqualified opinion. The balance sheet shows an equity share capital of ₹427.35 lakh and borrowings of ₹243.17 lakh. Cash flow from operations was negative at ₹58.95 lakh, largely due to operating losses and finance costs, partially offset by proceeds from sale of assets. The company continues to manage its low asset base and liquidity cautiously.